44
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Seeking wisdom from the Seer

&
Pages 145-147 | Received 10 Dec 2008, Accepted 13 Dec 2008, Published online: 01 Jul 2009

References

  • Pulte D, Gondos A, Brenner H. Long term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma 2009; 50: 179–186
  • Swenson W T, Wooldridge J E, Lynch C F, Forman-Hoffman V L, Chrischilles E, Link B K. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005; 23: 5019–5023
  • Fisher R I, LeBlanc M, Press O W, Maloney D G, Unger J M, Miller T P. New treatment options have changed the survival of patients with lymphoma. J Clin Oncol 2005; 23: 8447–8452
  • Liu Q, Fayad L, Cabanillas F, Hagemeister F B, Ayers G D, Hess M, et al. Improvement of overall and failure-free survival in stage IV for lymphoma: 25 years of treatment experience at The University of Texas MD Anderson Cancer Center. J Clin Oncol 2006; 24: 1582–1590
  • Hiddemann W, Hoster E, Buske C, Dreyling M, Kneba M, Hallek M, et al. Rituximab is the essential treatment modality that underlies the significant improvement in short and long term outcome of patients with advanced stage follicular lymphoma–a 10 year analysis of GLSG trials. Blood 2006; 108: 147a, (abstract 483)
  • Rohatiner A ZS, Nadler L, Davies A J, Apostolidis J, Neuberg D, Matthews J, et al. Myeloablative therapy with autologous bone marrow transplant for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 2007; 25: 2554–2559
  • Landmann E, Oschlies I, Zimmermann M, Moser O, Graf N, Suttorp M, et al. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL. Br J Haematol 2008; 143: 387–394
  • Evens A, Chiu B C. The challenges of epidemiologic research in non-Hodgkin lymphoma. JAMA 2008; 300: 2059–2061
  • Friedberg J W, Taylor M D, Cerhan J R, Flowers C R, Dillon H, Farber C M, et al. Follicular lymphoma in the United States: first report of the National LymphoCare Study. J Clin Oncol, doi: 10.1200/JCO.18.2008.1495
  • Levine M N, Julian J A. Registries that show efficacy: good, but not good enough. J Clin Oncol 2008; 26: 5316–5319

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.